New variant BA.3.2 Cicada of Covid-19 advances in American states and gains monitoring

The new BA.3.2 variant of Covid-19, also known as Cicada, records detections in at least 25 states of Estados Unidos. Health authorities are monitoring the advancement of this lineage with a high number of mutations in the spike protein. While overall cases of Covid remain low nationally, the strain has gained momentum in several countries since last fall. Especialistas highlight that genetic changes can reduce protection from previous infections or from vaccines administered.
The variant emerged in África from Sul in November 2024 as a descendant of BA.3, an omicron sublineage that briefly circulated in 2022. From September 2025, detections began to increase in different regions of the world, including the Estados Unidos.
- BA.3.2 has between 70 and 75 mutations in the spike protein compared to recent variants.
- This number of changes makes it genetically distinct from the JN.1 lineages that served as the basis for the 2025-2026 vaccines.
- Laboratory studies indicate potential for immune escape, although more data on the real impact is still needed.
Genetic characteristics of the Cicada variant
The BA.3.2 lineage presents a series of substitutions and deletions that differentiate its spike protein from others in circulation. Virologistas note that these changes can make the virus appear less familiar to the human immune system. However, some mutations also reduce their ability to bind to human cells, which may limit their transmission efficiency in certain contexts.
Public health experts emphasize that the variant has not yet demonstrated a sustained growth advantage over the current dominant strains. Organização Mundial of

Dissemination in the Estados Unidos and the world
The first detection of BA.3.2 in Estados Unidos occurred in June 2025, in a traveler returning from Holanda and passing through Aeroporto Internacional of São Francisco. Desde then, positive samples appeared in international travelers, patients with symptoms and wastewater analyses. Até February 2026, the strain had been identified in 132 sewage samples from 25 different states.
The variant also circulates in at least 23 countries. In nations such as Dinamarca, Alemanha and Holanda, it accounted for around 30% of sequences analyzed between November 2025 and January 2026. Dados most recent wastewater surveillance programs indicate presence in 3.7% of samples nationwide.
BA.3.2 did not outperform predominant variants like XFG and its descendants. The absence of a significant increase in the total number of cases suggests that, for now, it circulates coexisting with other lineages. Autoridades health authorities maintain monitoring to identify any change in the spread pattern.
Symptoms associated with BA.3.2 infection
The symptoms reported in BA.3.2 cases follow the pattern observed in other Covid-19 variants currently circulating. Pacientes may present respiratory and systemic manifestations that vary in intensity depending on the individual profile. Most cases progress mildly and resolve with basic supportive care.
The most common signs include cough, fever or chills, sore throat and nasal congestion. Outros common symptoms involve shortness of breath, fatigue, headache and changes in smell or taste. Alguns individuals also report gastrointestinal discomfort such as nausea, vomiting or diarrhea. Esses conditions usually disappear within a few days with rest and adequate hydration.
Experts reinforce that there is no evidence of an increase in disease severity or hospitalization rates associated specifically with this variant. The strain remains sensitive to antivirals available for treating Covid-19. The clinical picture is not significantly different from infections caused by other omicron lineages in circulation.
Efficacy of vaccines and prevention measures
Vaccines against Covid-19 formulated for the JN.1 lineage offer protection against severe forms of the disease even in the face of variants such as BA.3.2. Estudos laboratories show a reduction in the neutralization of antibodies against this new strain, but observational data is still limited. Current formulations continue to reduce the risk of serious complications in vulnerable groups.
People over the age of 65 or with pre-existing conditions that compromise the immune system must keep their vaccination schedule up to date. Especialistas recommend talking to doctors about the need for booster doses when the interval since the last application exceeds six to twelve months. Annual vaccination helps boost immunity against multiple circulating strains.
Simple measures remain effective in limiting transmission. Testar If symptoms appear, staying at home when sick and wearing masks in closed or crowded environments reduces the risk of contagion. Hand hygiene and ventilation of indoor spaces also contribute to controlling spread in communities.
Continuous monitoring of variant evolution
Public health authorities utilize multiple surveillance strategies, including genomic sequencing of clinical samples, monitoring of travelers, and analysis of wastewater. Esses systems made it possible to identify BA.3.2 early in different regions. Combining data helps map lineage progression without relying solely on reports of symptomatic cases.
Experts highlight that Covid-19 follows a pattern of constant evolution, with the periodic emergence of new variants. BA.3.2 represents a genetically distinct lineage that deserves attention, although it has not caused significant waves to date. Laboratory and epidemiological monitoring continues to assess any change in the behavior of the virus.
The presence of the variant in sewage samples indicates wider circulation than the number of confirmed cases suggests. Programas like WastewaterSCAN records consistent detections across multiple locations. Essa tool provides early clues about transmission trends in areas where clinical testing is less frequent.
Recommendations for at-risk populations
Individuals with greater susceptibility to complications from Covid-19 should prioritize prevention. Isso includes elderly adults, people with immunosuppression and people with chronic diseases such as diabetes, hypertension or heart and lung problems. Dialogue with healthcare professionals helps to define personalized protection strategies.
Maintaining healthy habits, such as a balanced diet and regular physical activity, supports the proper functioning of the immune system. In periods of greater viral circulation, avoiding unnecessary crowds and ensuring good ventilation in indoor environments helps to reduce exposures. Essas actions are in addition to available vaccines and treatments.
The Cicada variant has not yet generated a significant increase in the total number of hospitalizations or deaths in the places where it circulates. The current scenario differs from the initial phases of the pandemic, when variants caused more intense impacts on public health. Continuous monitoring provides support for timely adjustments to preventive recommendations.






